The New York Times reports that a number of companies and research institutes are pursuing gene therapies.
In Genome Research this week: population dynamics of E. coli infection, lncRNA expression changes in macaque aging, and more.
A US Food and Drug Administration panel recommends that the agency approve a gene therapy for pediatric leukemia, the New York Times reports.
In Nature this week: new Neanderthal mitochondrial genome, and more.
Independent research teams took a look at the mutations, gene fusions, and other alterations that may inform pediatric T-ALL treatment and outcome predictions.
The organization named the institutions that will be performing the proteomic and proteogenomic analyses planned to for the five-year, $65 million effort.
In Science this week: click chemistry for evaluating therapies, and more.
In PNAS this week: genetic feature of ALL relapse in Down syndrome patients, Plasmodium falciparum parasite strain structure, and more.
The agency approved Novartis' Rydapt for AML patients with FLT3 mutations, who will be identified by Invivoscribe's LeukoStrat CDx.
Parental smoking linked to deletions observed among children with acute lymphoblastic leukemia, CBS News reports.
Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.
Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.
In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.